Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy

被引:0
|
作者
Weissenborn, K [1 ]
Berding, G
Köstler, H
机构
[1] Med Hsch Hannover, Dept Neurol, D-30623 Hannover, Germany
[2] Med Hsch Hannover, Dept Nucl Med, D-30623 Hannover, Germany
[3] Med Hsch Hannover, Dept Neuroradiol, D-30623 Hannover, Germany
关键词
D-2 dopamine receptor; dopamine transporter; hepatic encephalopathy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient suffering from liver cirrhosis presented with a bradykinetic-rigid syndrome suspected as Parkinson's disease. A detailed work-up of the case revealed hepatic encephalopathy as the cause of the neurological symptomatology. An alteration of striatal dopamine D-2 receptor binding and dopamine re-uptake sites was demonstrated by I-123-iodobenzamide (IBZM) and I-123-beta -CIT single photon emission computed tomography (SPECT), respectively. It is suggested that the alteration of the dopamine re-uptake in cirrhotics may be the cause of an increased catabolism of dopamine in HE.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 50 条
  • [21] Striatal dopamine (D2) receptor availability predicts socially desirable responding
    Reeves, Suzanne J.
    Mehta, Mitul A.
    Montgomery, Andrew J.
    Amiras, Dimitri
    Egerton, Alice
    Howard, Robert J.
    Grasby, Paul M.
    NEUROIMAGE, 2007, 34 (04) : 1782 - 1789
  • [22] Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons
    Sciamanna, Giuseppe
    Napolitano, Francesco
    Pelosi, Barbara
    Bonsi, Paola
    Vitucci, Daniela
    Nuzzo, Tommaso
    Punzo, Daniela
    Ghiglieri, Veronica
    Ponterio, Giulia
    Pasqualetti, Massimo
    Pisani, Antonio
    Usiello, Alessandro
    NEUROBIOLOGY OF DISEASE, 2015, 78 : 146 - 161
  • [23] Dopamine D2 receptor levels, in extrastriatal and striatal regions in schizophrenia.
    Kessler, RM
    Ansari, MS
    Li, R
    Dawant, B
    Meltzer, HY
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 36P - 36P
  • [24] THRESHOLD FOR VISUAL AWARENESS IS ASSOCIATED WITH STRIATAL DOPAMINE D2 RECEPTOR BINDING
    Van Opstal, Filip
    Verguts, Tom
    Van Laecken, Nick
    De Vos, Filip
    Goethals, Ingeborg
    Fias, Wim
    JOURNAL OF COGNITIVE NEUROSCIENCE, 2013, : 264 - 264
  • [25] Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo
    Pohjalainen, T
    Rinne, JO
    Någren, K
    Syvälahti, E
    Hietala, J
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (06): : 768 - 773
  • [26] Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas
    Vernaleken, Ingo
    Janouschek, Hildegard
    Raptis, Mardjan
    Hellmann, Sandra
    Veselinovic, Tanja
    Broecheler, Anno
    Boy, Christian
    Cumming, Paul
    Hiemke, Christoph
    Roesch, Frank
    Schaefer, Wolfgang M.
    Gruender, Gerhard
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (07): : 951 - 960
  • [27] Dopamine D2 receptor-dependent modulation of striatal NO synthase activity
    Sammut, Stephen
    Bray, Kristina E.
    West, Anthony R.
    PSYCHOPHARMACOLOGY, 2007, 191 (03) : 793 - 803
  • [28] Ketamine does not decrease striatal dopamine D2 receptor binding in man
    Aalto, S
    Hirvonen, J
    Kajander, J
    Scheinin, H
    Någren, K
    Vilkman, H
    Gustafsson, L
    Syvälahti, E
    Hietala, J
    PSYCHOPHARMACOLOGY, 2002, 164 (04) : 401 - 406
  • [29] Ketamine does not decrease striatal dopamine D2 receptor binding in man
    Sargo Aalto
    Jussi Hirvonen
    Jaana Kajander
    Harry Scheinin
    Kjell Någren
    Harry Vilkman
    Lars Gustafsson
    Erkka Syvälahti
    Jarmo Hietala
    Psychopharmacology, 2002, 164 : 401 - 406
  • [30] Varenicline increases striatal dopamine D2/3 receptor binding in rats
    Crunelle, Cleo L.
    Miller, Michelle L.
    de Bruin, Kora
    van den Brink, Wim
    Booij, Jan
    ADDICTION BIOLOGY, 2009, 14 (04) : 500 - 502